More than a number: Incorporating the aged phenotype to improve in vitro and in vivo modeling of neurodegenerative disease

Laura M. Carr,Sanam Mustafa,Andrew Care,Lyndsey E Collins-Praino

DOI: https://doi.org/10.1016/j.bbi.2024.04.023

IF: 19.227

2024-04-27

Brain Behavior and Immunity

Abstract:Age is the number one risk factor for developing a neurodegenerative disease (ND), such as Alzheimer's disease (AD) or Parkinson's disease (PD). With our rapidly ageing world population, there will be an increased burden of ND and need for disease-modifying treatments. Currently, however, translation of research from bench to bedside in NDs is poor. This may be due, at least in part, to the failure to account for the potential effect of ageing in preclinical modelling of NDs. While ageing can...

immunology,neurosciences,psychiatry